Ginkgo Bioworks Holdings (DNA) Exchange Rate Effect (2021 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly Exchange Rate Effect came in at $43000.0 in Q2 2026, down 76.88% on a YoY basis from $186000.0 in Q2 2025, and up 133.33% quarter-over-quarter from -$129000.0 in Q1 2026.
Analysis
Ginkgo Bioworks Holdings (DNA) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Exchange Rate Effect for 6 consecutive years, with $43000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect fell 76.88% year-over-year to $43000.0; the trailing twelve-month figure through Jun 2026 stood at -$145000.0 (down 195.39% YoY), and the FY2025 full-year result was $201000.0, up 171.53% from the prior year.
- Exchange Rate Effect grew to $43000.0 in Q2 2026 per DNA's latest filing, from -$129000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2022 and bottomed at -$469000.0 in Q2 2023.
- Historically, Exchange Rate Effect has averaged $8555.6 across 5 years, with a median of -$30500.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect soared 10090.91% in 2022, then plunged 503.85% in 2024.
- Over 5 years, Exchange Rate Effect stood at $1.1 million in 2022, then tumbled by 90.72% to $102000.0 in 2023, then slumped by 171.57% to -$73000.0 in 2024, then tumbled by 108.22% to -$152000.0 in 2025, then surged by 128.29% to $43000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $43000.0, -$129000.0, and -$152000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | -1.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 221,000.00 |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | -781,000.00 |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | -1.60 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | -800,000.00 |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 43,000.00 |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -21,155.67 |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43,000.00 |
| Mar 31, 2026 | -129,000.00 |
| Dec 31, 2025 | -152,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | -73,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -157,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Sep 30, 2023 | -195,000.00 |
| Jun 30, 2023 | -469,000.00 |
| Mar 31, 2023 | -26,000.00 |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | -87,000.00 |
| Jun 30, 2022 | -96,000.00 |
| Mar 31, 2022 | -8,000.00 |
| Dec 31, 2021 | -11,000.00 |
| Sep 30, 2021 | -877,000.00 |